Top Section/Ad
Top Section/Ad
Most recent
Shareholders sell down holdings in AutoStore and Orsted, as shipping company opens books ahead of Athens parallel listing
Deeply discounted financing allows embattled iron ore miner to restart Ukrainian production and shares to resume trading
International investors take most of the book for the first time as Zabłocki's investment firm says it expects to make no further sales
Food systems company’s largest shareholder raises €324m after shares rise on strong results and buyback
More articles/Ad
More articles/Ad
More articles
-
Hansoh Pharmaceutical Group, a China-based drug maker, pocketed HK$3.49bn ($450m) from a larger-than-planned issue of primary shares this week. -
Europe's equity capital market bankers are expecting a resurgence of secondary share sales by investors over the coming weeks as financial sponsors look to take advantage of the rebound in global equity markets since the start of the pandemic to raise cash to redeploy elsewhere.
-
With its more relaxed rules around pre-emption rights, the UK has led from the front by allowing embattled companies to raise equity to keep themselves alive during the coronavirus pandemic. The market's flexibility means there have been no damaging delays waiting for for formal rule changes. Such pragmatism is admirable, although more must be done to protect retail investors from dilution.
-
The Covid-19 global pandemic is not an unmitigated disaster for everyone, as several companies showed on Monday night by selling new shares to take advantage of the unexpected opportunities that the pandemic has created for them.
-
Sino Biopharmaceutical’s shares tumbled about 8% on Tuesday after its chief executive officer, Tse Ping, sold a portion of his stake in the company for HK$2.27bn ($292.9m).
-
SK E&S, a South Korean energy company, has raised HK$11.55bn ($1.49bn) by selling most of its shares in China Gas Holdings near the top of the marketed range.
